Journal Watch · ACS Nano · 2026

H<sub>2</sub>S-Activable BiFeO<sub>3-<i>x</i></sub> Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy.

This work establishes a defect-chemistry-oriented design framework for engineering redox-programmable nano semiconductors that translate lattice instability into biological selectivity, bridging ferroelectric materials science and immune oncology.

Liang J, Luo X, Shi YQ et al.ACS Nano3 min readPharma relevance 40/100

DOI: 10.1021/acsnano.5c18008PMID: 41622764Study type: research study

TL;DR

This work establishes a defect-chemistry-oriented design framework for engineering redox-programmable nano semiconductors that translate lattice instability into biological selectivity, bridging ferroelectric materials science and immune oncology.

Key findings

  • Biologically, this multiresponse process initiates mitochondrial collapse, glutathione peroxidase 4 depletion, and lipid peroxide accumulation, driving apoptosis-ferroptosis cascades. <i>In vivo</i>, photoacoustic-guided therapy and mass cytometry profiling reveal profound immune remodeling, such as dendritic cell maturation, CD8<sup>+</sup> T cell infiltration, and M1 macrophage polarization, implying the conversion of "cold" colorectal tumors into immunogenic tumor microenvironments.
  • This work establishes a defect-chemistry-oriented design framework for engineering redox-programmable nano semiconductors that translate lattice instability into biological selectivity, bridging ferroelectric materials science and immune oncology.

What they did

Upon exposure to tumor-enriched gasotransmitter H<sub>2</sub>S, BiFeO<sub>3-<i>x</i></sub> undergoes a transformation into Bi<sub>2</sub>S<sub>3</sub> while releasing Fe<sup>2+</sup> ions to trigger Fenton-like lipid peroxidation. The material's mixed-valence Fe redox pair amplifies reactive oxygen species generation under 808 nm excitation, coupling photothermal energy dissipation with catalytic ferroptotic stress.

Full abstract (original)

Background: Controlling ferroptosis through material redox dynamics represents a frontier in the field of catalytic nanomedicine. Here, we introduce nonstoichiometric bismuth ferrite (BiFeO<sub>3-<i>x</i></sub>) as an H<sub>2</sub>S-activable semiconductor that couples oxygen-vacancy-enabled charge modulation with endogenous sulfur chemistry to achieve spatiotemporally controlled immunogenic ferroptosis.

What they did: Upon exposure to tumor-enriched gasotransmitter H<sub>2</sub>S, BiFeO<sub>3-<i>x</i></sub> undergoes a transformation into Bi<sub>2</sub>S<sub>3</sub> while releasing Fe<sup>2+</sup> ions to trigger Fenton-like lipid peroxidation. The material's mixed-valence Fe redox pair amplifies reactive oxygen species generation under 808 nm excitation, coupling photothermal energy dissipation with catalytic ferroptotic stress.

Results & conclusions: Biologically, this multiresponse process initiates mitochondrial collapse, glutathione peroxidase 4 depletion, and lipid peroxide accumulation, driving apoptosis-ferroptosis cascades. <i>In vivo</i>, photoacoustic-guided therapy and mass cytometry profiling reveal profound immune remodeling, such as dendritic cell maturation, CD8<sup>+</sup> T cell infiltration, and M1 macrophage polarization, implying the conversion of "cold" colorectal tumors into immunogenic tumor microenvironments. This work establishes a defect-chemistry-oriented design framework for engineering redox-programmable nano semiconductors that translate lattice instability into biological selectivity, bridging ferroelectric materials science and immune oncology.

Abstract © the authors / ACS Nano (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1021/acsnano.5c18008 · PubMed 41622764.

Why it matters for pharma & biotech

  • Relevant to Biotechnology & Methods teams tracking ACS Nano for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this ACS Nano study find?

This work establishes a defect-chemistry-oriented design framework for engineering redox-programmable nano semiconductors that translate lattice instability into biological selectivity, bridging ferroelectric materials science and immune oncology.

What type of study is this?

It is a research study, published in ACS Nano in 2026. Upon exposure to tumor-enriched gasotransmitter H<sub>2</sub>S, BiFeO<sub>3-<i>x</i></sub> undergoes a transformation into Bi<sub>2</sub>S<sub>3</sub> while releasing Fe<sup>2+</sup> ions to trigger Fenton-like lipid peroxidation.

Where can I read the original paper?

The original is at the publisher via DOI 10.1021/acsnano.5c18008. PubMed ID: 41622764. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Liang J, Luo X, Shi YQ et al.. H&lt;sub&gt;2&lt;/sub&gt;S-Activable BiFeO&lt;sub&gt;3-&lt;i&gt;x&lt;/i&gt;&lt;/sub&gt; Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy.. ACS Nano (2026). DOI: 10.1021/acsnano.5c18008.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/h-lt-sub-gt-2-lt-sub-gt-s-activable-bifeo-lt-sub-gt-3-lt-i-gt-x-lt-i-gt-c18008/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides